Coladonin, a natural sesquiterpene coumarin ether isolated from Ferula tunetana, along with seven ester derivatives were investigated as inhibitors of human carbonic anhydrases IX and XII (hCA IX/XII). A series of coladonin-derived analogues (7a-g) was synthesized and tested against five CA isoforms (hCA I, II, IV, IX, XII). Coladonin 6 and its trifluoracetyl derivative 7e strongly and selectively inhibited hCA IX (Ki = 90 and 70 nM, respectively) and hCA XII (Ki = 210 and 110 nM, respectively). Compound 7e exhibited better selectivity on hCA IX than acetazolamide (AAZ). The antimelanoma and antiglioblastoma efficacy of coladonin 6 and 7e was evaluated in vitro under hypoxic conditions. Both compounds displayed significant antiproliferative effects, markedly better than those of the reference hCA IX/XII inhibitor SLC-0111 currently in clinical phase IIb. These results highlight coladonin 6 as a promising scaffold for developing selective hCA IX/XII inhibitors targeting hypoxic tumors.

Selective Inhibition of Carbonic Anhydrase IX and XII by Natural Coumarin Coladonin and Its Derivatives: Promising Antimelanoma and Antiglioblastoma Agents

Massardi M. L.;Ronca R.;
2025-01-01

Abstract

Coladonin, a natural sesquiterpene coumarin ether isolated from Ferula tunetana, along with seven ester derivatives were investigated as inhibitors of human carbonic anhydrases IX and XII (hCA IX/XII). A series of coladonin-derived analogues (7a-g) was synthesized and tested against five CA isoforms (hCA I, II, IV, IX, XII). Coladonin 6 and its trifluoracetyl derivative 7e strongly and selectively inhibited hCA IX (Ki = 90 and 70 nM, respectively) and hCA XII (Ki = 210 and 110 nM, respectively). Compound 7e exhibited better selectivity on hCA IX than acetazolamide (AAZ). The antimelanoma and antiglioblastoma efficacy of coladonin 6 and 7e was evaluated in vitro under hypoxic conditions. Both compounds displayed significant antiproliferative effects, markedly better than those of the reference hCA IX/XII inhibitor SLC-0111 currently in clinical phase IIb. These results highlight coladonin 6 as a promising scaffold for developing selective hCA IX/XII inhibitors targeting hypoxic tumors.
File in questo prodotto:
File Dimensione Formato  
2025 ACS Medicinal Chemistry Letters_antiGBM e melanoma.pdf

gestori archivio

Tipologia: Full Text
Licenza: NON PUBBLICO - Accesso privato/ristretto
Dimensione 2.95 MB
Formato Adobe PDF
2.95 MB Adobe PDF   Visualizza/Apri   Richiedi una copia

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11379/634390
 Attenzione

Attenzione! I dati visualizzati non sono stati sottoposti a validazione da parte dell'ateneo

Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus 1
  • ???jsp.display-item.citation.isi??? 1
social impact